Aim: To find new genetic loci associated with statin response, and to investigate the association of a genetic risk score (GRS) with this outcome.

Patients & Methods: In a discovery meta-analysis (five studies, 1991 individuals), we investigated the effects of approximately 50000 single nucleotide polymorphisms on statin response, following up associations with p < 1 × 10(-4) (three independent studies, 5314 individuals). We further assessed the effect of a GRS based on SNPs in ABCG2, LPA and APOE.

Results: No new SNPs were found associated with statin response. The GRS was associated with reduced statin response: 0.0394 mmol/l per allele (95% CI: 0.0171-0.0617, p = 5.37 × 10(-4)).

Conclusion: The GRS was associated with statin response, but the small effect size (˜2% of the average low-density lipoprotein cholesterol reduction) limits applicability.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558527PMC
http://dx.doi.org/10.2217/pgs.16.8DOI Listing

Publication Analysis

Top Keywords

statin response
20
associated statin
12
genetic risk
8
risk score
8
low-density lipoprotein
8
lipoprotein cholesterol
8
grs associated
8
associated
5
statin
5
response
5

Similar Publications

Background: Numerous meta-analyses have identified various risk factors for hepatocellular carcinoma (HCC), prompting a comprehensive study to synthesize evidence quality and strength.

Methods: This umbrella review of meta-analyses was conducted throughout PubMed, EMBASE, Web of Science, and Cochrane Database of Systematic Reviews. Evidence strength was evaluated according to the evidence categories criteria.

View Article and Find Full Text PDF

Manifestations of human atherosclerosis across vascular beds.

JVS Vasc Insights

May 2024

Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University.

Objective: Atherosclerosis underlies the most common etiologies of mortality worldwide, resulting in nearly 10 million deaths annually. In atherosclerosis, inflammation, metabolic factors, and hemodynamics cause the accumulation of extracellular lipids and the formation of plaques in the tunica intima of specific arteries. Atherosclerotic plaques primarily form in the coronary and carotid arteries, the aorta, and the peripheral arteries of the lower extremities.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the effects of statins on 30-day mortality in patients with sepsis-associated encephalopathy (SAE), finding a generally positive impact on survival rates.
  • Statins like simvastatin showed a significant decrease in mortality risk, while rosuvastatin was linked to a higher risk of death.
  • Results suggest that statin use can be beneficial across various demographics and clinical conditions in SAE patients.
View Article and Find Full Text PDF

GWAS of CRP response to statins further supports the role of APOE in statin response: A GIST consortium study.

Pharmacol Res

January 2025

Centre of Clinical Pharmacology & Precision Medicine, William Harvey Research Institute, Queen Mary University of London, London, UK; NIHR Barts Biomedical Research Centre, Queen Mary University of London, London, UK. Electronic address:

Article Synopsis
  • Statins are key medications used to prevent cardiovascular disease by not only lowering lipids but also reducing inflammation, measured by C-reactive protein (CRP).
  • Two significant genetic loci linked to how individuals respond to statin treatment in terms of changes in CRP levels were identified: APOE and HNF1A, both of which are associated with various health conditions like coronary artery disease and diabetes.
  • Further analysis suggests that the APOE-E4 variant may influence the effectiveness of statins, hinting at its potential role in personalized healthcare for those with cardiovascular and related conditions.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!